Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	13.15B -17.9%
Revenue (ttm)	630.37M +25.6%
Net Income	200.19M +36.8%
EPS	1.46 +36.4%
Shares Out	137.75M
PE Ratio	65.38
Forward PE	48.21
Dividend	0.80 (0.84%)
Ex-Dividend Date	May 29, 2025

Volume	342,543
Average Volume	369,631
Open	95.48
Previous Close	94.87
Day's Range	94.02 - 96.11
52-Week Range	93.15 - 132.94
Beta	0.26
RSI	43.39
Earnings Date	Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2025, SHA:688198's revenue was 630.37 million, an increase of 25.60% compared to the previous year's 501.88 million. Earnings were 200.19 million, an increase of 36.81%.